| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Universal Health Services, Inc. Class B$159.31
-2.9 (-1.86%)
Market Cap
11.04 B
EPS
23.48
P/E Ratio
7.81 $
Value Trade
203.59 M
SEC Financials
Q1 2026Dilution Risk
Revenue
4.50 B
Operating CF
401.63 M
Total Assets
15.68 B
Total Liabilities
15.68 B
Equity
7.46 B
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
252.55 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 7, 2026
Overview
Volume
1.66 M
52 Week Range
152.33 - 246.33
% held by Insiders
16.76 %
% held by Institutions
88.28 %
Enterprise Value
16.20 B
Total Shares
53.83 M
Short %
6.75 %
Float Shares
51.14 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in UHS
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
UHS Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-UHS
Jul 27, 2026▼ -1.9%today
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
Universal Health Services, Inc. (UHS) reported a net income of $358.4 million for Q2 2026, reflecting an increase from $353.2 million in Q2 2025. The company also saw an 8.3% rise in net revenues to $4.638 billion during the same period. However, UHS revised its 2026 full-year operating results forecast, indicating a potential decrease in adjusted EBITDA compared to earlier projections. The company continues to invest in its facilities and services to enhance patient care.
Read more →-UHS
Jul 15, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
Universal Health Services, Inc. has declared a cash dividend of $0.20 per share, payable on September 15, 2026, to shareholders on record as of September 1, 2026. This announcement reflects the company's ongoing commitment to rewarding its investors. UHS is recognized as a leading provider of healthcare services across the U.S., Puerto Rico, and the UK.
Read more →-UHS
Jul 6, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Universal Health Services, Inc. has announced the date for its second quarter 2026 earnings release, set for July 27, 2026. A conference call for investors will follow on July 28, 2026, at 9:00 a.m. ET. The company emphasizes its commitment to investor relations through live webcasts and detailed participation instructions.
Read more →-UHS
May 27, 2026UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCE
Universal Health Services, Inc. is set to present at the Goldman Sachs Annual Global Healthcare Conference on June 9, 2026. The presentation will be accessible via a live audio webcast, highlighting the company's role as a leading provider of healthcare services across the U.S., U.K., and Puerto Rico. This event underscores UHS's commitment to investor engagement.
Read more →-UHS
Apr 27, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026
Universal Health Services, Inc. reported strong financial results for the first quarter of 2026, with net income rising to $348.7 million, up from $316.7 million in the same period last year. The company experienced a 9.6% increase in net revenues, totaling $4.495 billion. Adjusted EBITDA also saw growth, reaching $648.3 million. However, rising operating expenses and interest costs present challenges for future profitability.
Read more →-UHS
Mar 9, 2026Universal Health Services, Inc. to Acquire Talkspace, Inc. Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care King of Prussia, PA and New York, NY (
Universal Health Services (UHS) has entered a definitive agreement to acquire Talkspace for $5.25 per share, totaling an enterprise value of approximately $835 million. This acquisition is expected to enhance UHS's outpatient and telehealth behavioral health strategies, providing greater access to mental healthcare services. The deal, which has received approval from both boards of directors, will close in Q3 2026, pending stockholder and regulatory approvals. UHS anticipates this merger to be accretive to its net income in the first year post-closing.
Read more →-UHS
Feb 28, 2024Universal Health Services, Inc. Selected Hospital Statistics For the Three Months Ended
Universal Health Services, Inc. reported selected hospital statistics for the three months ending December 31, 2023. The data indicates a modest increase in the number of hospitals owned and leased, as well as in average licensed and available beds. Additionally, patient days and admissions saw an uptick, reflecting higher utilization of healthcare services. Overall, the occupancy rates have shown slight improvements compared to the same period in the previous year.
Read more →-UHS
Dec 7, 2022SEPARATION AGREEMENT AND GENERAL RELEASE UHS of Delaware, Inc. ("UHS" or "Employer") and Marvin Pember ("Employee") (together, "Parties") enter into this Separation Agreement and General Release ("Agreement") effective a
SEPARATION AGREEMENT AND GENERAL RELEASE UHS of Delaware, Inc. ("UHS" or "Employer") and Marvin Pember ("Employee") (together, "Parties") enter into this Separation Agreement and General Release ("Agreement") effective as of December 31, 2022 ("Effective Date"). WHEREAS, UHS an
Read more →-UHS
Jul 10, 2020Steve Filton Chief Financial Officer
CONTACT:Steve Filton Chief Financial OfficerJuly 10, 2020 UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINAL SETTLEMENT RESOLVING THE GOVERNMENT'S INVESTIGATION OF OUR BEHAVIORAL HEALTH CARE FACILITIES KING OF PRUSSIA, PA - Universal Health Services, Inc. (NYSE: UHS; the "Compan
Read more →-UHS
Apr 26, 2019Universal Health Services, Inc. Selected Hospital Statistics For the three months ended
Universal Health Services, Inc. Selected Hospital Statistics For the three months ended March 31, 2019 and 2018 AS REPORTED: BEHAVIORAL HEALTH 03/31/19 03/31/18 % change Hospitals owned and leased 327 300 9.0 % Average licensed beds 23,941 2
Read more →-UHS
Dec 6, 2018Universal Health Services, Inc. Announces Retirement of Debra K. Osteen, President of the Behavioral Health Division 12/6/2018
Universal Health Services, Inc. Announces Retirement of Debra K. Osteen, President of the Behavioral Health Division KING OF PRUSSIA, Pa., December 6, 2018 Universal Health Services, Inc. (NYSE: UHS) today announced that Debra K. Osteen, President of the Behavioral Health Divis
Read more →-UHS
Dec 8, 2016Steve Filton
CONTACT: Steve Filton December 8, 2016 Chief Financial Officer 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. STATEMENT REGARDING RECENT BUZZFEED ARTICLE KING OF PRUSSIA, PA- Universal Health Services, Inc. (NYSE:UHS) issued the following statement today in respo
Read more →-UHS
May 19, 2016Universal Health Services, Inc. Announces Offering Of Senior Secured Notes
Universal Health Services, Inc. Announces Offering Of Senior Secured Notes KING OF PRUSSIA, Pa., May 19, 2016 /PRNewswire/ Universal Health Services, Inc. (NYSE: UHS) today announced an offering of $800 million aggregate principal amount of 4.750% senior secured notes due 2022
Read more →-UHS
Apr 14, 2011UHS Commences Exchange Offer for 7% Senior Notes due 2018
UHS Commences Exchange Offer for 7% Senior Notes due 2018 PRUSSIA, PA, April 14, 2011 Universal Health Services, Inc. (NYSE: UHS) today announced the commencement of an exchange offer for its outstanding 7% Senior Notes due 2018 (the outstanding notes ) that were originally iss
Read more →-UHS
Apr 1, 2011REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Shareholders of Universal Health Services, Inc.: In our opinion, the consolidated financial statements listed in the accompanying inde
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Universal Health Services, Inc.: In our opinion, the consolidated financial statements listed in the accompanying index present fairly, in all material respects, the financial position of Uni
Read more →-UHS
Mar 16, 2011UNIVERSAL HEALTH SERVICES, INC. AMENDS CREDIT AGREEMENT AND INCREASES 2011 EARNINGS GUIDANCE KING OF PRISSIA, PA - Universal Health Services, Inc. (NYSE:UHS) announced today that the Company has completed an Amendment to
UNIVERSAL HEALTH SERVICES, INC. AMENDS CREDIT AGREEMENT AND INCREASES 2011 EARNINGS GUIDANCE KING OF PRISSIA, PA - Universal Health Services, Inc. (NYSE:UHS) announced today that the Company has completed an Amendment to the Credit Agreement, dated November 15, 2010. The Amen
Read more →-UHS
Nov 15, 2010Universal Health Services Completes Acquisition of Psychiatric Solutions
Universal Health Services Completes Acquisition of Psychiatric Solutions KING OF PRUSSIA, Pa., November 15, 2010 -- Universal Health Services, Inc. (NYSE: UHS) ("UHS") announced today that it has completed its previously announced acquisition of Psychiatric Solutions, Inc. (NASD
Read more →-UHS
Sep 14, 2010Capitalization The following table sets forth our capitalization as of
The following table sets forth our capitalization as of June 30, 2010: (amounts in thousands) As of June 30, 2010 Actual Pro forma as adjusted Cash and cash equivalents $ 12,337 $ 12,337 Total debt (including current maturities) Existing revolving credit facility 1
Read more →-UHS
Sep 14, 2010Steve Filton Chief Financial Officer 610-768-3300
UNIVERSAL HEALTH SERVICES INC. ANNOUNCES OFFERING OF SENIOR NOTES KING OF PRUSSIA, PA, September 14, 2010 Universal Health Services, Inc. (NYSE: UHS) today announced an offering of $250.0 million aggregate principal amount of senior unsecured notes due 2018 (the Notes ). The No
Read more →-UHS
Jun 24, 2010Sources and Uses subsection of
Sources and Uses subsection of June 24, 2010 Presentation to Prospective Lenders illustrates sources and uses for the proposed transaction: Sources and uses ($ millions) Sources Uses Balance sheet cash $ 108 Purchase PSYS equity $ 1,983 New $800mm Revolver 322 Refin
Read more →-UHS
Jun 15, 2010J.P. MORGAN SECURITIES INC. 270 Park Avenue New York, New York 10017 DEUTSCHE BANK SECURITIES INC. 60 Wall Street New York, New York 10005 JPMORGAN CHASE BANK, N.A. 270 Park Avenue New York, New York 10017 DEUTSCHE BANK
J.P. MORGAN SECURITIES INC. 270 Park Avenue New York, New York 10017 DEUTSCHE BANK SECURITIES INC. 60 Wall Street New York, New York 10005 JPMORGAN CHASE BANK, N.A. 270 Park Avenue New York, New York 10017 DEUTSCHE BANK AG NEW YORK BRANCH 60 Wall Street New York, New York 10005
Read more →Competitive Position
How UHS ranks across every disease it competes inCompetitive Position is a premium feature
See how UHS ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial